Managers

Inivata snags $52.6 mln Series B

Inivata, a provider of liquid biopsy, has raised $52.6 million in Series B funding. The investors were Woodford Patient Capital Trust, IP Group, Cambridge Innovation Capital, Johnson & Johnson Innovation – JJDC and RT Ventures.

On the Bleeding Edge: SXSW: founder diversity; DWS (drunk while scootering)

Cloud fuels today’s startups, but big companies may own the next wave of innovation

Chris Schaepe ousted from Lightspeed over ties to college admissions scandal

Alpha Venture Partners to make 3x on Careem

Cannabis-focused Hypur Ventures launches $500 mln fund

Hypur Ventures, which focuses on the legal cannabis industry, has launched a $500 million fund. Hypur Ventures II plans to invest in private companies with seasoned operators, with investments ranging between $1 million to $25 million.

Health2047 Capital collects $30 mln for inaugural fund

Health2047 Capital Partners, a Silicon Valley-based healthcare-focused venture firm, has raised $30 million for its debut fund, according to an SEC filing. The target is $250 million.

ATAI Life Sciences nets $43 mln Series B

ATAI Life Sciences, a global biotech platform focused on curing mental health disorders, has raised $43 million in Series B financing. Subversive Capital led the round.

The changing nature of startup innovation

Swiss biotech company Polyneuron inks funding

Polyneuron Pharmaceuticals AG, a Swiss biotech firm, has secured CHF22.5 million ($22.6 million) in Series A financing. The investors included Sofinnova Partners and New Enterprise Associates.